Audio
.jpg?impolicy=website&width=360&height=270 "How to build a unicorn in 6 years")
-
Is Sputnik V the shot in the arm India needs?
As India's inoculation drive slows down, Russia's Sputnik V is the third vaccine in the country's kitty. With the necessary approvals in place, at least six manufacturers in India, including the Hetero Group of Companies, will be making a total of 900 million doses of the contentious vaccine. Divya Shekhar and Manu Balachandran give you a peek into the big gambit to ramp up production of the Sputnik V in India
-
A snapshot of the 12th Anniversary Special
For Forbes India's 12th anniversary, the team came up with 12 pertinent topics or sectors and challenges that India faces today, and invited experts like CEOs, investors, entrepreneurs, economists, philanthropers, to write about their vision for the future of that idea. The topics range from mobility to healthcare, food to luxury, entertainment and sports, jobs and inequality, philanthropy, and more. Ruchika Shah gives you a peek into the Anniversary special issue with a quick snapshot of the wealth of essays you'll find in it
-
AU Small Finance's Sanjay Agarwal shows financial inclusion can be a viable business
Sanjay Agarwal built AU Small Finance Bank into a $4.4 billion giant by taking banking to the hinterland. Forbes India's Samar Srivastava gives you a peek into the latest Forbes India cover story
-
Inside our latest edtech issue
Sequoia Capital bet big on education technology—ed tech—with over a dozen investments, including in industry giants Byju's and Unacademy. Forbes India' Rajiv Singh unpacks the cover story of the fortnight
-
Inside our 2021 investment special issue
A peek into our 2021 Investment Special where we dissect and analyse the parameters that will shape investment strategies for the new financial year. Forbes India's Salil Panchal and Samar Srivastava take you through what you can expect in the new issue which is on stands now
-
.jpg?impolicy=website&width=360&height=270 "Inside Forbes India Best Employer 2021 in association with Kincentric")
Inside Forbes India Best Employer 2021 in association with Kincentric
In the second annual Best Employer issue of Forbes India, the focus was on how the companies navigated the Covid-19 pandemic, making the well being of their employees a priority. Monica Bathija walks you through the process of choosing the best from the Kincentric survey and putting the issue together
-
.jpg?impolicy=website&width=360&height=270 "Inside Forbes India Leadership Awards 2021")
Inside Forbes India Leadership Awards 2021
After the crucial year that was, the 10th edition of Forbes India Leadership Awards 2021 (FILA 2020) commemorates the leaders that stood out for taking the lead on tackling the Covid-19 challenge, steering with grit and vision and looking after their people and businesses. Salil Panchal takes you through what went on behind the scenes in putting our annual flagship issue together
-
.jpg?impolicy=website&width=360&height=270 "Regional Goliaths: Inside the Davids of India taking on the Goliaths")
Regional Goliaths: Inside the Davids of India taking on the Goliaths
Local players turned into regional brands and are now are shedding their avatars of being the little guy and are taking over larger MNC rivals in the regions they operate in. Cover story author and special package anchor Rajiv Singh takes you through the journey of a clutch of these regional brands whose stories you will find in our latest issue
-
Inside 'unicorn hunters' Accel India's VC play, and our PE/VC special
How Accel India sniffs out good opportunities early, invests in entrepreneurs' passion, and leads them to unicorn status. Cover story author Rajiv Singh calls Accel India 'unicorn hunters', where the founding partners bring their entrepreneurial experience to investing. Forbes India's Pooja Sarkar speaks about Apollo Global's big play in distressed assets in India and why it will eye big PE deals going forward
-
Recognising the unsung heroes of 2020
As life as we knew it came to a standstill in 2020, we capture both the spirit of innovation that prevailed in India during the pandemic, and acknowledge the various unsung heroes of Covid-19—from doctors to nurses, women of SHGs, municipal workers and ambulance drives, among so many others, who put their safety at stake to keep others safe
-
Inside Zydus Cadila's Covid-19 vaccine—ZyCov-D—play
It took them a record 10 months to develop a H1N1 vaccine. Now Sharvil Patel, managing director, and his team at Zydus Cadila are trying to bring a Covid-19 vaccine by March 2021. Manu Balachandran and Divya Shekhar who have been closely following the vaccine race and India's play in it, take you behind the scenes of the ongoings at the Ahmedabad-based pharmaceutical